Doug Hampton SAN FRANCISCO, June 8, 2023 /PRNewswire/ — Roo, the leading marketplace for veterinary staffing solutions, is pleased to have surpassed over 4,000 hospitals, veterinarians and veterinary technicians utilizing Roo for their staffing needs, and earning steady wages on a full-time or part-time basis. This achievement firmly establishes its position as a key player in the … Read more
COPENHAGEN, Denmark, June 8, 2023 /PRNewswire/ — Zerion Pharma A/S (‘ZERION’) today announces the publication of joint experimental work on its Dispersome® technology in the International Journal of Pharmaceutics and Pharmaceutical Research, two peer-reviewed papers. The work behind the publications originated from two partnership projects, one with Bayer AG and one with Novartis Pharma AG. … Read more
(ETX Daily Up) – We know that sport is beneficial for health, but associated with the virtues of the ocean, its benefits would be increased tenfold. A finding that gave birth in the 1990s to surf therapy, a discipline that is increasingly emulated in France and around the world. On the occasion of World Oceans … Read more
the essential Opposed to a bill supposed to improve access to care, the association Doctors for tomorrow calls on general practitioners to close their practices this Friday, June 9. The bill of the deputy Horizon Frédéric Valletoux, which will be presented next week to the National Assembly, does not pass with the doctors. These are … Read more
KANSAS CITY, Mo., June 8, 2023 /PRNewswire/ — Liquid Mobile, formerly Liquid Mobile IV, is revolutionizing access to health and wellness by expanding offerings and changing its name to better represent a commitment to providing groundbreaking access to whole-body wellness. The Kansas-City based company is launching new services straight to consumers’ doorsteps in June 2023, … Read more
KT430 is a preclinical, next-generation investigational gene therapy to treat X-linked myotubular myopathy (XLMTM) TOKYO and SAN DIEGO, June 8, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”), and Kate Therapeutics (“KateTx”) today announced an exclusive license agreement to develop and commercialize KT430. KT430 is a preclinical next-generation investigational … Read more
Series A financing co-led by Westlake Village BioPartners and Versant Ventures Company advancing systemically delivered, skeletal and cardiac muscle targeted, liver de-targeted capsid and cargo technology platforms Initial pipeline addressing myotonic dystrophy type 1 and facioscapulohumeral muscular dystrophy Company grants Astellas Pharma Inc. exclusive license to KT430 to treat X-linked myotubular myopathy SAN DIEGO, June … Read more
JINAN, China, June 8, 2023 /PRNewswire/ — Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the 2023 American Society of Clinical Oncology Annual Meeting (ASCO 2023). Study One:Title: DUBHE-L-304: A randomized, double-blind, multicenter … Read more
If the link is already known with metabolic diseases and certain cancers, a new study evokes depressive symptoms. As we know, over-consumption of ultra-processed foods is associated with a greater risk of obesity, diabetes, or cancer, and cognitive decline. This time, a study by Tasnime Akbaraly’s team, researcher Inserm at the Center for Research in … Read more
the essential Suffering from stiff man syndrome, Celine Dion has canceled all her concerts in Europe until 2024. To combat the disease, the Quebec singer is undergoing heavy treatment which would cost her 40,000 euros per month. “It would be unfair to you to postpone the concerts once again, and although it breaks my heart, … Read more